In the present study, we demonstrate that luteoloside is a potent agent against human hepatoma cells both in vitro and in vivo, and NLRP3 inflammasome might be involved in the signaling of luteoloside-induced suppression of proliferation, migration and invasion. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.